Promising phase 2 results for new plaque psoriasis therapy
1. Guselkumab, an anti-interleukin-23 antibody, produced better responses in patients with moderate to severe plaque psoriasis than standard anti-TNF alpha ...
Tag: psoriasis
Standardized measures effectively tracked psoriasis and acne outcomes
1. Using the Physician Global Assessment (PGA), patients with acne or psoriasis recorded significant improvement in disease severity at 3-month ...
Brodalumab may be effective for difficult-to-treat psoriasis
1. Treatment with brodalumab was shown to be safe and efficacious in patients with psoriatic arthritis or who previously failed ...
Patient Basics: Psoriasis
Originally published by Harvard Health. What Is It? Psoriasis is a chronic skin disorder that causes scaling and inflammation. Psoriasis may ...
Severe psoriasis linked with poorly controlled blood pressure
1. Psoriasis severity was associated with an increased likelihood of uncontrolled hypertension. Evidence Rating Level: 2 (Good) Study Rundown: Psoriasis ...
Ixekizumab may be safe and effective for chronic plaque psoriasis
1. The use of 120mg ixekizumab in a phase-III, open-label extension (OLE) trial showed improved Psoriasis Area and Severity Index ...
Hypertension and use of β-blockers linked to increased risk of psoriasis
1. A history of hypertension for 6 or more years was linked with an increased risk of psoriasis in US ...
